VIOLIN: Vaccine Investigation and Online Information Network

Vaccine Detail

MUC-2-Globo H-KLH Conjugate Vaccine

Vaccine Information

Vaccine Name: MUC-2-Globo H-KLH Conjugate Vaccine
Target Pathogen: Cancer
Target Disease: Cancer
Vaccine Ontology ID: VO_0007563
Type: Conjugate vaccine
Status: Clinical trial
Host Species for Licensed Use: Human
Host Species as Laboratory Animal Model: Human
MUC2 gene engineering:
- Type: Recombinant protein preparation
- Description: (Slovin et al., 2005)
- Detailed Gene Information: Click Here.
Description: NULL

Host Response

References

Slovin et al., 2005: Slovin SF, Ragupathi G, Fernandez C, Jefferson MP, Diani M, Wilton AS, Powell S, Spassova M, Reis C, Clausen H, Danishefsky S, Livingston P, Scher HI. A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21. Vaccine. 2005; 23(24); 3114-3122. [PubMed: 15837210].